Skip to main content

Organon

Organon & Co is an American global healthcare company focused on women's health, biosimilars, and established prescription medicines. The company manufactures and markets contraception products, fertility treatments, biosimilar therapies, and cardiovascular and respiratory medicines spun off from Merck & Co. Main revenue drivers consist of global commercial sales of Nexplanon, NuvaRing, biosimilars, and legacy established prescription pharmaceuticals. Organon serves gynecologists, fertility specialists, hospital networks, prescription pharmacies, and female patients across North America, Europe, Asia, and Latin America. The company holds a market-leading global position in women's health therapeutics and reproductive health solutions. Headquartered in Jersey City, New Jersey, Organon & Co is listed on the New York Stock Exchange.

9 of the funds FundTelligence covers report a position in Organon.

Legal name
Organon & Co
Sector
Health Care
Country
United States
Funds holding it
9

Funds holding Organon

Showing the 8 largest of 9 funds holding it.

Loading...